Literature DB >> 21074751

Molecular approaches to improving general anesthetics.

Stuart A Forman1.   

Abstract

Over the last several decades, the average age of patients has steadily increased, whereas the use of general anesthesia and deep sedation has grown largely outside the operating room environment. Currently available general anesthetics and delivery models represent limitations in addressing these trends. At the same time, research has tremendously expanded the knowledge of how general anesthetics produce their beneficial effects and also revealed evidence of previously unappreciated general anesthetic toxicities. The goal of this review is to highlight these important developments and describe translational research on new general anesthetics with the potential to improve and reshape clinical care.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074751      PMCID: PMC2990980          DOI: 10.1016/j.anclin.2010.08.004

Source DB:  PubMed          Journal:  Anesthesiol Clin        ISSN: 1932-2275


  57 in total

1.  General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.

Authors:  Rachel Jurd; Margarete Arras; Sachar Lambert; Berthold Drexler; Roberta Siegwart; Florence Crestani; Michael Zaugg; Kaspar E Vogt; Birgit Ledermann; Bernd Antkowiak; Uwe Rudolph
Journal:  FASEB J       Date:  2002-12-03       Impact factor: 5.191

Review 2.  Mechanisms of actions of inhaled anesthetics.

Authors:  Jason A Campagna; Keith W Miller; Stuart A Forman
Journal:  N Engl J Med       Date:  2003-05-22       Impact factor: 91.245

3.  Identification of sites of incorporation in the nicotinic acetylcholine receptor of a photoactivatible general anesthetic.

Authors:  M B Pratt; S S Husain; K W Miller; J B Cohen
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

4.  Water-soluble propofol analogues with intravenous anaesthetic activity.

Authors:  A Cooke; A Anderson; K Buchanan; A Byford; D Gemmell; N Hamilton; P McPhail; S Miller; H Sundaram; P Vijn
Journal:  Bioorg Med Chem Lett       Date:  2001-04-09       Impact factor: 2.823

5.  Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome.

Authors:  C Ikonomidou; P Bittigau; M J Ishimaru; D F Wozniak; C Koch; K Genz; M T Price; V Stefovska; F Hörster; T Tenkova; K Dikranian; J W Olney
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

6.  Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat.

Authors:  Daqing Ma; Hong Yang; John Lynch; Nicholas P Franks; Mervyn Maze; Hilary P Grocott
Journal:  Anesthesiology       Date:  2003-03       Impact factor: 7.892

7.  Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients.

Authors:  L S Rasmussen; T Johnson; H M Kuipers; D Kristensen; V D Siersma; P Vila; J Jolles; A Papaioannou; H Abildstrom; J H Silverstein; J A Bonal; J Raeder; I K Nielsen; K Korttila; L Munoz; C Dodds; C D Hanning; J T Moller
Journal:  Acta Anaesthesiol Scand       Date:  2003-03       Impact factor: 2.105

Review 8.  Anaesthetic drugs: linking molecular actions to clinical effects.

Authors:  Christian Grasshoff; Berthold Drexler; Uwe Rudolph; Bernd Antkowiak
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

9.  The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Authors:  Sachin Patel; Eric R Wohlfeil; David J Rademacher; Erica J Carrier; LaToya J Perry; Abhijit Kundu; J R Falck; Kasem Nithipatikom; William B Campbell; Cecilia J Hillard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

10.  Effects of xenon on in vitro and in vivo models of neuronal injury.

Authors:  Stefan Wilhelm; Daqing Ma; Mervyn Maze; Nicholas P Franks
Journal:  Anesthesiology       Date:  2002-06       Impact factor: 7.892

View more
  8 in total

1.  Two etomidate sites in α1β2γ2 γ-aminobutyric acid type A receptors contribute equally and noncooperatively to modulation of channel gating.

Authors:  Grigori Guitchounts; Deirdre S Stewart; Stuart A Forman
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

2.  A newly developed anesthetic based on a unique chemical core.

Authors:  Noëlie S Cayla; Beza A Dagne; Yun Wu; Yao Lu; Larry Rodriguez; Daryl L Davies; Eric R Gross; Boris D Heifets; M Frances Davies; M Bruce MacIver; Edward J Bertaccini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-15       Impact factor: 11.205

3.  Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain.

Authors:  Selwyn S Jayakar; Xiaojuan Zhou; David C Chiara; Carlos Jarava-Barrera; Pavel Y Savechenkov; Karol S Bruzik; Mariola Tortosa; Keith W Miller; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2019-04-05       Impact factor: 4.436

4.  High-throughput Screening in Larval Zebrafish Identifies Novel Potent Sedative-hypnotics.

Authors:  Xiaoxuan Yang; Youssef Jounaidi; Jennifer B Dai; Francisco Marte-Oquendo; Elizabeth S Halpin; Lauren E Brown; Richard Trilles; Wenqing Xu; Renee Daigle; Buwei Yu; Scott E Schaus; John A Porco; Stuart A Forman
Journal:  Anesthesiology       Date:  2018-09       Impact factor: 7.892

5.  A paradigm shift from biophysical to neurobiological: the fading influence of Claude Bernard's ideas about general anesthesia.

Authors:  Stuart A Forman
Journal:  Anesthesiology       Date:  2013-04       Impact factor: 7.892

6.  Anesthetic drug development: Novel drugs and new approaches.

Authors:  Hovig V Chitilian; Roderic G Eckenhoff; Douglas E Raines
Journal:  Surg Neurol Int       Date:  2013-03-19

7.  Functional sites for anesthetics in GABAA receptors.

Authors:  Maria C Maldifassi; Erwin Sigel
Journal:  Oncotarget       Date:  2017-02-14

8.  Novel positive allosteric modulators of GABAA receptors with anesthetic activity.

Authors:  Maria C Maldifassi; Roland Baur; David Pierce; Anahita Nourmahnad; Stuart A Forman; Erwin Sigel
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.